Shanghai Yizhong Pharmaceutical Co., Ltd.

SSE:688091.SS

45.78 (CNY) • At close June 10, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Operating Activities:
Net Income 000.1615.33129.17830.9326.51449.08555.02538.68943.18730.23530.74416.127-7.898-6.722-5.504-7.165-4.744-4.364-5.574
Depreciation & Amortization 0002.8422.8422.326-3.4391.7641.7641.621.621.5941.5946.594-3.3193.31906.166-3.0131.5131.5
Deferred Income Tax 0000053.30400070.0230-0.953000000000
Stock Based Compensation 0009.786027.2710000.78400000000000
Change In Working Capital 000-9.710-80.57560.414-60.4140-33.73828.641-28.6410-31.80320.637-20.63700.696-0.3670.098-1.989
Accounts Receivables 000-7.6420-69.19362.37-62.370-28.45820.466-20.4660-21.49920.983-20.9830-0.5570.807-0.372-0.434
Change In Inventory 000-2.0680-11.381-1.9571.9570-5.288.174-8.1740-10.304-0.3460.34601.253-1.1730.1411.032
Change In Accounts Payables 000000000000000000000
Other Working Capital 0000000000000000000-0.043-3.021
Other Non Cash Items 0020.27-11.5312.12520.348-72.50448.866-1.764-38.689-30.26-30.235-30.744-16.1277.8986.7225.5047.1654.744-1.143-1.277
Operating Cash Flow 0020.431-9.04231.3030.310.98539.30155.02538.68943.187-0-0-3.896-7.88-15.797-17.149-5.91-3.065-3.896-7.34
Investing Activities:
Investments In Property Plant And Equipment -0.427-27.401-35.671-10.149-6.815-0.107-1.017-3.267-4.39-5.108-12.785-4.568-13.42-0.958-0.729-0.397-1.059-0.582-1.682-1.872-0.868
Acquisitions Net 000000-539.2564.202,568.57-1,438.571,438.57000000000
Purchases Of Investments 001,470-1,4700-1,332.5539.2-539.20-2,568.571,438.57-1,438.570-1,513.850000000
Sales Maturities Of Investments 2,265.2440.559-8855603251,418.54.11213.2821.9998.8982.62810.0185.3213.6921.69800.5430.6932.1550.1151.177
Other Investing Activites -2,2782.99-137.989305-305-4318-25259.173-18.453342.952177.618-487.67-318.66214.2262.7732.199-8.54916.6287.585
Investing Cash Flow -13.183-23.852411.34-615.14913.18542.89321.09510.01522.60912.962-28.611348.402169.519-484.936-317.69214.2262.7732.31-8.07714.8717.894
Financing Activities:
Debt Repayment 0-10.9-20.109.123.9000-16.7500-14.9300000000
Common Stock Issued 0000000000000-76.0030000000
Common Stock Repurchased 000000000000000000000
Dividends Paid 0-0.008-0.119-49.373-0.295-0.027-0.095-43.2860-0.352-0.14-0.005-0.135-0.172-0.187000000
Other Financing Activities 2.5899.465-27.936-22.10020.1-43.286016.75-0.14-1.8250-7.539935.8441.64914.8713.25000
Financing Cash Flow 2.589-1.443-48.155-71.4738.80567.28120.005-43.2860-0.352-0.14-1.825-15.065-7.711935.8441.64914.8713.25000
Other Information:
Effect Of Forex Changes On Cash 00000-5.339-4.112-13.2820-27.06926.9727.91421.23200000000
Net Change In Cash -46.056-6.724383.616-706.73159.482105.13447.972-7.25252.44524.2341.409354.491175.686-500.063610.27115.7317.453-0.35-11.14210.9760.554
Cash At End Of Period 598.351644.407651.13267.514974.246914.763799.412751.439758.691706.247682.017640.608286.117110.431610.49315.87417.6450.1910.54111.6830.708